Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery Via Suprachoroidal Space Injection In Peer-Reviewed Industry Journal, RETINA
Portfolio Pulse from Benzinga Newsdesk
Clearside Biomedical has announced the publication of consensus guidelines for drug delivery via suprachoroidal space (SCS) injection in the peer-reviewed journal RETINA. An expert panel of ophthalmologists developed these guidelines, which support SCS injection as a safe and effective method for delivering retinal and choroidal therapeutics.
May 21, 2024 | 11:13 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clearside Biomedical's publication of guidelines for suprachoroidal space injection in a peer-reviewed journal is a positive development. The expert panel's support for the technique as safe and effective could enhance the company's reputation and adoption of its technology.
The publication in a peer-reviewed journal and endorsement by an expert panel can significantly boost Clearside Biomedical's credibility and the adoption of its SCS injection technology. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100